|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/16/20 Apollo Medical Holdings, Inc. 10-K 12/31/19 116:18M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.55M
2: EX-4.10 Instrument Defining the Rights of Security Holders HTML 41K
3: EX-14.1 Code of Ethics HTML 49K
4: EX-21.1 Subsidiaries List HTML 37K
5: EX-23.1 Consent of Experts or Counsel HTML 34K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 42K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 42K
8: EX-31.3 Certification -- §302 - SOA'02 HTML 42K
9: EX-32 Certification -- §906 - SOA'02 HTML 42K
114: R1 Document and Entity Information HTML 67K
51: R2 Consolidated Balance Sheets HTML 198K
37: R3 Consolidated Balance Sheets (Parenthetical) HTML 56K
76: R4 Consolidated Statements of Income HTML 128K
113: R5 Consolidated Statements of Mezzanine and HTML 141K
Shareholders' Equity
50: R6 Consolidated Statements of Mezzanine and HTML 35K
Shareholders' Equity (Parenthetical)
36: R7 Consolidated Statements of Cash Flows HTML 230K
74: R8 Consolidated Statements of Cash Flows HTML 36K
(Parenthetical)
116: R9 Description of Business HTML 62K
78: R10 Basis of Presentation and Summary of Significant HTML 236K
Accounting Policies
92: R11 Business Combination and Goodwill HTML 137K
58: R12 Land, Property and Equipment, Net HTML 56K
19: R13 Intangible Assets, Net HTML 133K
79: R14 Investments in Other Entities HTML 214K
94: R15 Loans Receivable and Loans Receivable - Related HTML 44K
Parties
59: R16 Accounts Payable and Accrued Expenses HTML 53K
20: R17 Medical Liabilities HTML 54K
80: R18 Credit Facility, Bank Loan and Lines of Credit - HTML 94K
Related Party
91: R19 Income Taxes HTML 133K
49: R20 Mezzanine and Shareholders' Equity HTML 269K
35: R21 Commitments and Contingencies HTML 49K
75: R22 Related Party Transactions HTML 60K
112: R23 Employee Benefit Plan HTML 37K
52: R24 Revenue Recognition HTML 39K
38: R25 Earnings Per Share HTML 71K
77: R26 Variable Interest Entities (VIEs) HTML 117K
115: R27 Leases HTML 151K
48: R28 Basis of Presentation and Summary of Significant HTML 262K
Accounting Policies (Policies)
39: R29 Basis of Presentation and Summary of Significant HTML 121K
Accounting Policies (Tables)
18: R30 Business Combination and Goodwill (Tables) HTML 124K
55: R31 Land, Property and Equipment, Net (Tables) HTML 54K
96: R32 Intangible Assets, Net (Tables) HTML 225K
82: R33 Investments in Other Entities (Tables) HTML 179K
17: R34 Accounts Payable and Accrued Expenses (Tables) HTML 53K
54: R35 Medical Liabilities (Tables) HTML 53K
95: R36 Credit Facility, Bank Loan and Lines of Credit - HTML 52K
Related Party (Tables)
81: R37 Income Taxes (Tables) HTML 129K
16: R38 Mezzanine and Shareholders' Equity (Tables) HTML 229K
56: R39 Related Party Transactions (Tables) HTML 44K
34: R40 Earnings Per Share (Tables) HTML 70K
46: R41 Variable Interest Entities (VIEs) (Tables) HTML 120K
106: R42 Leases (Tables) HTML 128K
68: R43 Description of Business - Additional Information HTML 175K
(Details)
33: R44 Basis of Presentation and Summary of Significant HTML 138K
Accounting Policies - Additional Information
(Details)
45: R45 Basis of Presentation and Summary of Significant HTML 41K
Accounting Policies - Additional Information,
Performance Obligation (Details)
105: R46 Basis of Presentation and Summary of Significant HTML 46K
Accounting Policies - Disaggregation of Revenue by
Payor Type (Details)
67: R47 Basis of Presentation and Summary of Significant HTML 56K
Accounting Policies - Contributions to Revenue and
Receivables by Payor (Details)
32: R48 Basis of Presentation and Summary of Significant HTML 53K
Accounting Policies - Carrying Amounts and Fair
Values of Company's Financial Instruments
(Details)
47: R49 Business Combination and Goodwill - Additional HTML 177K
Information (Details)
65: R50 Business Combination and Goodwill - Total Purchase HTML 48K
Consideration (Details)
25: R51 Business Combination and Goodwill - Calculated HTML 41K
Based on Number of Shares of Combined Company
Pre-Merger (Details)
83: R52 Business Combination and Goodwill - Assumption of HTML 118K
Identifiable Assets Acquired and Liabilities
(Details)
97: R53 Business Combination and Goodwill - Pro Forma HTML 55K
Combined Historical Results (Details)
66: R54 Business Combination and Goodwill - Pro Forma HTML 46K
Financial Information All 2019 Acquisitions
(Details)
26: R55 Business Combination and Goodwill - Goodwill Roll HTML 45K
Forward (Details)
84: R56 Land, Property and Equipment, Net - Schedule of HTML 70K
Land, Property and Equipment, Net (Details)
98: R57 Land, Property and Equipment, Net - Additional HTML 38K
Information (Details)
64: R58 Intangible Assets, Net - Schedule of Intangible HTML 87K
Assets (Details)
27: R59 Intangible Assets, Net - Additional Information HTML 44K
(Details)
70: R60 Intangible Assets, Net - Schedule of Future HTML 50K
Amortization Expense (Details)
109: R61 Investments in Other Entities - Equity Method HTML 55K
(Details)
41: R62 Investments in Other Entities - Additional HTML 329K
Information (Details)
29: R63 Investments in Other Entities - Summarized Balance HTML 106K
Sheets and Statements of Income (Details)
71: R64 Loans Receivable and Loans Receivable - Related HTML 91K
Parties - Additional Information (Details)
110: R65 Accounts Payable and Accrued Expenses - Schedule HTML 54K
of Accounts Payable and Accrued Expenses (Details)
42: R66 Medical Liabilities - Schedule of Medical HTML 50K
Liabilities (Details)
30: R67 Credit Facility, Bank Loan and Lines of Credit - HTML 52K
Related Party - Schedule of Credit Facility
Information (Details)
73: R68 Credit Facility, Bank Loan and Lines of Credit - HTML 52K
Related Party - Schedule of Maturities (Details)
107: R69 Credit Facility, Bank Loan and Lines of Credit - HTML 222K
Related Party - Additional Information (Detail)
101: R70 Income Taxes - Income Tax Provision (Benefit) HTML 59K
(Details)
89: R71 Income Taxes - Additional Information (Details) HTML 66K
23: R72 Income Taxes - Deferred Tax Assets (Liabilities) HTML 94K
(Details)
62: R73 Income Taxes - Provision for Income Taxes HTML 66K
(Details)
100: R74 Mezzanine and Shareholders' Equity - APC (Details) HTML 64K
88: R75 Mezzanine and Shareholders' Equity - Shareholders' HTML 169K
Equity (Details)
22: R76 Mezzanine and Shareholders' Equity - Equity HTML 116K
Incentive Plans (Details)
61: R77 Mezzanine and Shareholders' Equity - Summary of HTML 162K
Stock Option Activity Under Black-Scholes Option
(Details)
103: R78 Mezzanine and Shareholders' Equity - Schedule of HTML 78K
Stock Options Activity (Details)
85: R79 Mezzanine and Shareholders' Equity - Summary of HTML 40K
Remaining Unrecognized Share based Compensation of
Stock Option (Details)
102: R80 Mezzanine and Shareholders' Equity - Warrants HTML 57K
Narrative (Details)
90: R81 Mezzanine and Shareholders' Equity - Summary of HTML 71K
Warrants (Details)
24: R82 Mezzanine and Shareholders' Equity - Warrants HTML 65K
(Details)
63: R83 Mezzanine and Shareholders' Equity - Dividends and HTML 63K
Treasury Stock (Details)
99: R84 Commitments and Contingencies - Additional HTML 70K
Information (Details)
87: R85 Related Party Transactions - Additional HTML 94K
Information (Details)
21: R86 Related Party Transactions - Schedule of Related HTML 46K
Party Transactions (Details)
60: R87 Employee Benefit Plan - Additional Information HTML 39K
(Details)
104: R88 Revenue Recognition - Additional Information HTML 45K
(Details)
86: R89 Earnings Per Share - Additional Information HTML 44K
(Details)
69: R90 Earnings Per Share - Basic Net Income (loss) Per HTML 50K
Share is Calculated Using Weighted Average Number
of Shares (Details)
108: R91 Earnings Per Share - Summary of Shares Included in HTML 55K
Diluted Earnings Per Share (Details)
40: R92 Variable Interest Entities (VIEs) - Eliminated HTML 171K
Upon Consolidation Included In Accompanying
Consolidated Balance Sheets (Details)
28: R93 Leases - Additional information (Details) HTML 60K
72: R94 Leases - Components of Lease Expense (Details) HTML 48K
111: R95 Leases - Other Information Related to Leases HTML 61K
(Details)
43: R96 Leases - Future Minimum Payments Under HTML 84K
Non-cancelable Leases After Adoption of 842
(Details)
31: R97 Leases - Future Minimum Payments Under HTML 72K
Non-cancelable Leases Prior to Adoption of 842
(Details)
44: R9999 Uncategorized Items - ameh-20191231.xml HTML 51K
57: XML IDEA XML File -- Filing Summary XML 214K
53: EXCEL IDEA Workbook of Financial Reports XLSX 174K
10: EX-101.INS XBRL Instance -- ameh-20191231 XML 5.14M
12: EX-101.CAL XBRL Calculations -- ameh-20191231_cal XML 456K
13: EX-101.DEF XBRL Definitions -- ameh-20191231_def XML 1.74M
14: EX-101.LAB XBRL Labels -- ameh-20191231_lab XML 3.39M
15: EX-101.PRE XBRL Presentations -- ameh-20191231_pre XML 2.15M
11: EX-101.SCH XBRL Schema -- ameh-20191231 XSD 357K
93: ZIP XBRL Zipped Folder -- 0001628280-20-003626-xbrl Zip 531K
| Exhibit |
1. | I have reviewed this annual report on Form 10-K of Apollo Medical Holdings, Inc.; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
DATE: | /s/ Eric Chin | |||
Chief Financial Officer | ||||
(Principal
Executive Officer) | ||||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/16/20 | |||
| For Period end: | 12/31/19 | 4, 4/A, 8-K | ||
| List all Filings | ||||